TRADE MARKS ACT 1995
DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS
Re:Opposition by ROCHE PRODUCTS LIMITED to registration of trade mark application 993199(25) - VALIUM AND DEVICE - filed in the name of HYLEBUT PTY LIMITED.
Delegate: | Don Nancarrow |
Representation: | Opponent: Gerard Skelly, Spruson & Ferguson, Sydney. Applicant: Caroline Ryan, DLA Phillips Fox, Brisbane. |
Decision: | 2007 ATMO 74 s. 52 opposition – s. 43: no connotation likely to deceive or confuse; s. 60: use of opposed trade mark likely to deceive or confuse in face of opponent’s deceptively similar trade mark with acquired reputation. Application refused. Costs – applicant to pay opponent’s costs. |
Background
Hylebut Pty Limited (‘the applicant’) filed application number 993199 on 16 March 2004 in class 25 of the International Classification of Goods and Services (‘Nice’ classification) in respect of ‘clothing, hats’. Other details of the application are set out below.
Trade mark:
Acceptance advertised: 15 July 2004
Roche Products Limited (‘the opponent’) filed a Notice of Opposition to the registration of this application on 15 October 2004 which nominated grounds under sections 41, 42(b), 43, 44, 58, 59, 60 and 62(b) of the Trade Marks Act 1995 (‘the Act’). Thereafter the parties served and filed evidence (in support and answer) in accord with the provisions of the Trade Mark Regulations 1995 (‘the Regulations’) and the matter was set down to be heard on 6 February 2007.
A matter of days prior to the hearing the applicant sought permission to serve further evidence in terms of Regulation 5.15. The opponent’s legal representative immediately responded that if the further evidence was admitted it wanted the opportunity to reply to this material. The hearing was cancelled and the evidence issues were addressed.
In addition to both of the parties serving their further evidence, Simon Williams, for the opponent, requested and was issued with a ‘Notice Requiring Production of a Document or Article’ under section 202 of the Act which it served on the applicant. The applicant provided a response that stated that the only information in its possession on the subjects raised in the ‘Notice to Produce Documents’ could be found in the earlier declaration (25 January 2007) of Michael Anthony McIntosh and outlined some specific points. Given the end result, I must confess to being somewhat confused by the introduction of the ‘Notice to Produce’. Apparently the ultimate intention of the opponent was to gain an admission from the applicant that it was aware of the opponent’s trade mark – yet this is implicit in McIntosh 2 (see The Evidence below) at ¶7 and explicit at ¶15 – in a declaration that was already in evidence. I had anticipated that the opponent had greater reason than this when the ‘Notice to Produce’ had been requested but, in the end, it did little more than delay the proceedings.
The matter was then set down, once again, to be heard on 23 August 2007 in Canberra. Gerard Skelly of Spruson & Ferguson, Sydney, appeared in…
Keep reading for free
Create a free CaseChat account to read Roche Products Limited v Hylebut Pty Limited and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2007] ATMO 74
- Decision Date
CaseChat Overview and Summary
The court was required to determine whether the applicant's proposed trade mark was deceptively similar to the opponent's registered trade mark, VALIUM, and whether, due to the reputation of the VALIUM trade mark, the use of the applicant's trade mark would be likely to deceive or cause confusion. The court also considered the relevance of a device element in the applicant's proposed mark and the extent of the reputation of the VALIUM trade mark in the Australian market for pharmaceuticals treating anxiety and tension.
The court found that the respective trade marks were substantially identical in their word components, with only minor differences in font. The device element in the applicant's mark, depicting a relaxed person, was considered to add little to visual differentiation and, in fact, could reinforce the conceptual link to the relaxing effect of the opponent's pharmaceutical products. Applying the concept of 'contextual confusion', the court concluded that the trade marks were deceptively similar. The court acknowledged the impressive reputation of the VALIUM trade mark, supported by substantial use since 1963 and significant public recognition demonstrated through various publications. The central question then became whether the applicant's proposed use of its trade mark, given the VALIUM trade mark's reputation, would likely deceive or cause confusion.
The court found that the respective trade marks were deceptively similar and that, due to the strong reputation of the VALIUM trade mark, the use of the applicant's trade mark would be likely to deceive or cause confusion. Consequently, the opposition was successful.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.